New Visualization: PD-1 Surface Expression Across CD8+ TIL Differentiation States I am sharing a violin-style visualization intended to communicate a well-established mechanistic trend in tumor immunology.

New Visualization: PD-1 Surface Expression Across CD8+ TIL Differentiation States I am sharing a violin-style visualization intended to communicate a well-established mechanistic trend in tumor immunology. I want to state at the outset that the data displayed are simulated. They do not derive from a specific experiment or dataset; rather, they are constructed to illustrate a literature-grounded pattern for pedagogical and discussion purposes. Figure title: "PD-1 (PDCD1) Surface Expression Across Tumor-Infiltrating T Cell Differentiation States." Subtitle: "Single-cell flow cytometry of CD8+ TILs stratified by exhaustion program, before and after anti-PD-1 blockade." The plot stratifies CD8+ tumor-infiltrating lymphocytes along the canonical exhaustion trajectory: progenitor/stem-like (TCF1+, PD-1 intermediate), transitional intermediate, and terminally exhausted (TOX-high, TIM-3+, PD-1 high) subsets. Each violin depicts the distribution of PD-1 surface mean fluorescence intensity on a per-cell basis, with paired pre- and post-anti-PD-1 blockade conditions displayed side by side. The illustrated trend reflects consensus observations: surface PD-1 density increases monotonically across the differentiation continuum, peaking in the terminally exhausted compartment concomitant with TOX-driven epigenetic commitment. Following anti-PD-1 administration, measured surface PD-1 declines, consistent with epitope masking by therapeutic antibody and receptor internalization rather than a genuine reduction in PDCD1 transcription. This distinction is mechanistically important, as apparent downregulation by flow cytometry does not indicate reversal of the exhaustion program. I would welcome feedback on how best to annotate the epitope-competition caveat for readers less familiar with flow-based receptor occupancy artifacts. Discussion regarding preferred clonal gating strategies is also appreciated.